--Financial Tools ---Futures Market---ADD HERE LINK-- OPTION ALERTS --BENZINGA--

« Home | Stocks to keep an eye on June 22, 2015 » | Stocks to keep an eye on June 19, 2015 » | Stocks to keep an eye on June 18, 2015 » | Stocks to keep an eye on June 17, 2015 » | Stocks to keep an eye on June 16, 2015 » | Stocks to keep an eye on June 15, 2015 » | Stocks to keep an eye on June 12, 2015 » | Stocks to keep an eye on June 10, 2015 » | Stocks to keep an eye on June 09, 2015 » | Stocks to keep an eye on June 08, 2015 » 

Monday, June 22, 2015 

Stocks to keep an eye on June 23, 2015

( click to enlarge )

Sorrento Therapeutics Inc (NASDAQ:SRNE) hit a new 52-week high today, trading as high as $17.05, before settling at a close of $16.82. I'll be watching the stock on Tuesday, looking for a follow through move. Resistance reflects today’s high of $17.05.

( click to enlarge )

Stratasys, Ltd. (NASDAQ:SSYS) has been trying to bottom for a couple of days now. There have been some pretty bullish candles forming on daily and it seems to me like it is ready to turn up. For the first time in weeks, RSI chart has a positive crossover, indicating bullish outlook and MACD still rising. The next major resistance level for stock is located at $38.44. A close above would be very bullish. On watch.

( click to enlarge )

Vascular Biogenics Ltd (NASDAQ:VBLT) is showing some signs of a possible reversal. The daily technical chart is now much improved after today’s action. The Slow Sto has reversed again the course and stock regained its 100-day EMA. I bought some today at $6.38 and I think that it could go to $8 relatively soon. On watch.

( click to enlarge )

Bullish volume pattern. Looks like Bioline RX Ltd (NASDAQ:BLRX) has a good chance to continue higher and a buy could be made as it moves over $2.30. If this happens, BLRX is a good play. The daily technical chart above shows the stock is on a bull market as the stock is trading above all EMAs and MACD has a bullish crossover. In addition, the stock was upgraded by JP Morgan and Roth Capital today with a target price of $5 and $10.5 respectively. Let's keep an eye on it as i think momentum will pick up.

( click to enlarge )

Celladon Corp (NASDAQ:CLDN) closed the day just above the break out point after some decent swings. The stock may attempt to go higher from here. If the near-by support at $2.23 (EMA13) holds up this week, a rally up to the $2.76 level is probable or even possible. Only a close below $2.23 would negate the positive outlook.


Disclaimer : This is not an investment advisory, and should not be used to make investment decisions. Information in AC Investor Blog is often opinionated and should be considered for information purposes only. No stock exchange anywhere has approved or disapproved of the information contained herein. There is no express or implied solicitation to buy or sell securities. The charts provided here are not meant for investment purposes and only serve as technical examples. Don't consider buying or selling any stock without conducting your own due diligence.

Thanks for visiting AC Investor Blog.

AC

Labels: , , , ,

Bookmark and Share

Photobucket Contact

About Me

    Photobucket
  • I'm a 43 year old Independent Trader using proprietary technical analysis with more than 18 years experience of investing in the US stock markets. I started this blog in 2006 simply as a way to share my thoughts about capital, risk management, and trading. My blog contains only my personal opinion and is provided for informational purposes only.

  • Benzinga.com supporter

    Stockal supporter

    Benzinga.com supporter



    FREE NEWSLETTER

      Enter your email address:

      Delivered by FeedBurner

      Subscribe my feed :

    Support AC

    • Support AC Investor Blog, Donate with PayPal

    Advertising

      Interested in advertising on AC Investor Blog ? Click Here

    QUOTES

    RECOMMENDED



    TRANSLATOR

    Site Information

    Stock Market Blogroll

    Friends BLOGROLL

    ARCHIVES

Powered by Blogger
and Blogger Templates


Add to Google